Serhan Alkan
Impact in
-
- Lymphoma Diagnosis and Treatment
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
Papers in
- Hematology 24
- Acute Myeloid Leukemia Research 14
-
- Lymphoma Diagnosis and Treatment 34
- Co-authors
- Eric D. HsiKeith F. IzbanHesham M. AminMelek ErginKevin BartonBertram SchnitzerMitchell F. DenningHongyu Ni
- Journals
- Blood (8 papers)American Journal of Clinical Pathology (8 papers)Leukemia Research (7 papers)Archives of Pathology & Laboratory Medicine (7 papers)British Journal of Haematology (6 papers)
- Partner nations
- United StatesChinaSingapore
In The Last Decade
Serhan Alkan
104 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 107
- Pathology and Forensic Medicine 860
- Hematology 526
- Oncology 1.2k
- Genetics 418
- Immunology 478
Countries citing papers authored by Serhan Alkan
This map shows the geographic impact of Serhan Alkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serhan Alkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serhan Alkan more than expected).
Fields of papers citing papers by Serhan Alkan
This network shows the impact of papers produced by Serhan Alkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serhan Alkan. The network helps show where Serhan Alkan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Serhan Alkan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2020 | 9 | |
| 3 | 2018 | 4 | |
| 4 | 2016 | 66 | |
| 5 | 2015 | 22 | |
| 6 | 2015 | 5 | |
| 7 | 2014 | 27 | |
| 8 | 2009 | 1 | |
| 9 | 2008 | 46 | |
| 10 | 2007 | 16 | |
| 11 | 2006 | 21 | |
| 12 | 2006 | 21 | |
| 13 | 2004 | 95 | |
| 14 | 2004 | 23 | |
| 15 | 2004 | 26 | |
| 16 | 2002 | 78 | |
| 17 | 2001 | 84 | |
| 18 | 2001 | 23 | |
| 19 | 2000 | 25 | |
| 20 | 1996 | 22 |
About Serhan Alkan
Serhan Alkan is a scholar working on Hematology, Pathology and Forensic Medicine, Genetics, Oncology and Immunology, having authored 104 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (34 papers), Viral-associated cancers and disorders (23 papers), Chronic Lymphocytic Leukemia Research (18 papers), Acute Myeloid Leukemia Research (14 papers), Ubiquitin and proteasome pathways (9 papers), Histone Deacetylase Inhibitors Research (8 papers), Protein Degradation and Inhibitors (8 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (860 citations), Hematology (526 citations), Oncology (1.2k citations), Genetics (418 citations) and Immunology (478 citations). Serhan Alkan has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Eric D. Hsi, Keith F. Izban, Hesham M. Amin, Melek Ergin, Kevin Barton, Bertram Schnitzer, Mitchell F. Denning, Hongyu Ni, Yu Wang and B J Nickoloff. Their work appears in journals such as Blood, American Journal of Clinical Pathology, Leukemia Research, Archives of Pathology & Laboratory Medicine and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.